The EU’s proposal for a revision of the general pharmaceutical legislation aims to ensure EU citizens have access to affordable medicines and that unmet medical needs are addressed – all wh
Patient care and healthcare provision have always appeared among society’s top priorities, but keeping people well came into sharp focus during the pandemic.
Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.